Edition:
United States

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

6.09USD
11:23am EDT
Change (% chg)

$0.09 (+1.50%)
Prev Close
$6.00
Open
$6.00
Day's High
$6.09
Day's Low
$6.00
Volume
1,688
Avg. Vol
4,060
52-wk High
$7.95
52-wk Low
$5.80

Select another date:

Tue, May 8 2018

BRIEF-Cumberland Pharmaceuticals Reports Q1 Adjusted Loss Per Share $0.09

* CUMBERLAND PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Cumberland Pharmaceuticals Expands Into Oncology Support

* CUMBERLAND PHARMACEUTICALS EXPANDS INTO ONCOLOGY SUPPORT Source text for Eikon: Further company coverage:

BRIEF-Cumberland Pharmaceuticals- Entered Agreement With Gastro-Entero Logic To Acquire Assets Associated With Omeclamox((Reg))-Pak

* CUMBERLAND PHARMACEUTICALS-ON MARCH 13, ENTERED AGREEMENT WITH GASTRO-ENTERO LOGIC, LLC TO ACQUIRE ASSETS ASSOCIATED WITH OMECLAMOX -PAK

BRIEF-Cumberland Pharma Q4 Adjusted Earnings Per Share $0.03

* CUMBERLAND PHARMACEUTICALS REPORTS 25% REVENUE GROWTH FOR THE FULL YEAR 2017

BRIEF-Cumberland Pharma Says Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients

* CUMBERLAND PHARMACEUTICALS INC - NEWLY PUBLISHED DATA DEMONSTRATES AMIFOSTINE REDUCES GASTRO-INTESTINAL TOXICITY FOR MULTIPLE MYELOMA PATIENTS Source text for Eikon: Further company coverage:

Select another date: